| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0272-6386(88)80221-X |
| P698 | PubMed publication ID | 3263042 |
| P2093 | author name string | McClellan W | |
| Issa A | |||
| Tuttle E | |||
| P2860 | cites work | Low-renin hypertension | Q39902823 |
| Racial factors in the incidence and causation of end-stage renal disease (ESRD). | Q43487801 | ||
| Renal Vasculature in Essential Hypertension: Racial Differences | Q46021966 | ||
| The epidemiology of end-state renal disease: the six-year South-Central Los Angeles experience, 1980-85. | Q53876789 | ||
| Blood pressure studies in 14 communities. A two-stage screen for hypertension | Q67021330 | ||
| Racial differences in the incidence of treatment for end-stage renal disease | Q70227290 | ||
| Race and end-stage renal disease | Q70227294 | ||
| P433 | issue | 4 | |
| P921 | main subject | kidney disease | Q1054718 |
| P304 | page(s) | 285-290 | |
| P577 | publication date | 1988-10-01 | |
| P1433 | published in | American Journal of Kidney Diseases | Q4744250 |
| P1476 | title | Racial differences in the incidence of hypertensive end-stage renal disease (ESRD) are not entirely explained by differences in the prevalence of hypertension | |
| P478 | volume | 12 |
| Q46949214 | "Strict" blood pressure control and progression of renal disease in hypertensive nephrosclerosis |
| Q35917504 | A 4.1-Mb congenic region of Rf-4 contributes to glomerular permeability |
| Q47789682 | APOL1 and Cardiovascular Disease: A Story in Evolution |
| Q33866444 | APOL1 renal risk variants have contrasting resistance and susceptibility associations with African trypanosomiasis |
| Q34383679 | APOL1 risk variants, race, and progression of chronic kidney disease |
| Q46250134 | Accuracy of the diagnosis of hypertensive nephrosclerosis in African Americans: a report from the African American Study of Kidney Disease (AASK) Trial. AASK Pilot Study Investigators |
| Q38031524 | Acute and chronic effects of angiotensin converting enzyme inhibitors on the essential hypertensive kidney |
| Q33721381 | Admixture mapping of end stage kidney disease genetic susceptibility using estimated mutual information ancestry informative markers. |
| Q41315333 | African-Americans on maintenance dialysis: a review of racial differences in incidence, treatment, and survival. |
| Q46401107 | Antihypertensive pharmacotherapy in a developing economy: pattern, acquisition costs and conformity to international guidelines in a tertiary-care setting |
| Q30437420 | Association analysis of the ephrin-B2 gene in African-Americans with end-stage renal disease |
| Q85763914 | Association of race and body mass index with ESRD and mortality in CKD stages 3-4: results from the Kidney Early Evaluation Program (KEEP) |
| Q40311503 | Association of race, heart failure and chronic kidney disease |
| Q37000882 | Biomarkers associated with pulse pressure in African-Americans and non-Hispanic whites |
| Q35645118 | Biomarkers of left ventricular hypertrophy and remodeling in blacks |
| Q90239146 | Black-White Difference in the Impact of Long-Term Blood Pressure From Childhood on Adult Renal Function: The Bogalusa Heart Study |
| Q57392523 | Black-white differences in subclinical cardiovascular disease among older adults: The cardiovascular health study |
| Q33785147 | CYP3A4 and CYP3A5 polymorphisms and blood pressure response to amlodipine among African-American men and women with early hypertensive renal disease |
| Q44043694 | Can glomerular mRNAs in human type 1 diabetes be used to predict transition from normoalbuminuria to microalbuminuria? |
| Q42551815 | Case reports: cocaine-associated accelerated hypertension and renal failure |
| Q46201041 | Causes of end-stage renal failure in black patients starting renal replacement therapy |
| Q41808742 | Changing patterns of end-stage renal disease due to hypertension |
| Q33266310 | Chronic kidney disease care delivered by US family medicine and internal medicine trainees: results from an online survey |
| Q39578231 | Cocaine use, hypertension, and end-stage renal disease |
| Q43750775 | Comparison of cross-sectional renal function measurements in African Americans with hypertensive nephrosclerosis and of primary formulas to estimate glomerular filtration rate |
| Q46262251 | Comparison of the prevalence of chronic kidney disease among different ethnicities: Beijing CKD survey and American NHANES. |
| Q61456443 | Consenso latino-americano de hipertensão em pacientes com diabetes tipo 2 e síndrome metabólica |
| Q44669203 | Decreases in renal functional reserve and proximal tubular fluid output in conscious oophorectomized rats: normalization with sex hormone substitution |
| Q34488558 | Design and statistical aspects of the African American Study of Kidney Disease and Hypertension (AASK). |
| Q80148236 | Different effects of angiotensin receptor blockade on end-organ damage in salt-dependent and salt-independent hypertension |
| Q44076782 | Early predictors of 15-year end-stage renal disease in hypertensive patients |
| Q46713830 | Effects of blood pressure control on progressive renal disease in blacks and whites. Modification of Diet in Renal Disease Study Group |
| Q37472864 | End-stage renal disease and race: an overview and perspective. |
| Q44860681 | End-stage renal disease in US minority groups |
| Q77550183 | End-stage renal failure in African Americans: insights in kidney disease susceptibility |
| Q33997784 | Essential hypertension and risk of nephropathy: a reappraisal |
| Q40899316 | Essential hypertension: a renal disease? A review and update of the evidence |
| Q31140524 | Ethnic differences in skin microvascular function and their relation to cardiac target-organ damage. |
| Q39851956 | Ethnicity, age and incidence rates for renal replacement therapy (RRT) in Birmingham, UK: 1990-2004. |
| Q74644319 | Excess risk of chronic kidney disease among African-American versus white subjects in the United States: a population-based study of potential explanatory factors |
| Q46604389 | Familial predisposition to nephropathy in African-Americans with non-insulin-dependent diabetes mellitus |
| Q46510550 | Family history of end-stage renal disease does not predict dialytic survival |
| Q34018541 | Genetic basis of nondiabetic end-stage renal disease |
| Q33734919 | Genetic susceptibility to end-stage renal disease. |
| Q40757473 | Hypertension and endstage renal disease |
| Q81305496 | Hypertension and the kidney |
| Q53858341 | Hypertension as a causative diagnosis of patients entering end-stage renal disease programs in the United States from 1980 to 1986. |
| Q37299028 | Hypertension-associated kidney disease: perhaps no more |
| Q57241673 | Hypertensive Retinopathy in Afro-Caribbeans and Europeans |
| Q40893426 | Hypertensive end-stage renal disease in blacks: the role of end-stage renal disease surveillance |
| Q46666495 | Hypertensive nephrosclerosis in African Americans |
| Q34461191 | Incidence and predictors of end stage renal disease among low-income blacks and whites |
| Q37178485 | Increased circulating inflammatory endothelial cells in blacks with essential hypertension |
| Q45853842 | Increasing incidence of human immunodeficiency virus-associated nephropathy at San Francisco General Hospital |
| Q70642277 | Kidney disease and hypertension in blacks: scope of the problem |
| Q46789333 | Kidney disease in the first-degree relatives of African-Americans with hypertensive end-stage renal disease |
| Q44615019 | Latin American consensus on hypertension in patients with diabetes type 2 and metabolic syndrome |
| Q34774598 | Long-term effects of renin-angiotensin system-blocking therapy and a low blood pressure goal on progression of hypertensive chronic kidney disease in African Americans |
| Q46833691 | Microalbuminuria and the metabolic syndrome in non-diabetic black Africans |
| Q33886637 | Multi-hit nature of chronic renal disease |
| Q36677384 | Neighborhood poverty and racial differences in ESRD incidence |
| Q36063726 | New insights and approaches to reduce end-organ damage in the treatment of hypertension: subsets of hypertension approach |
| Q37939566 | On the natural tendency to progressive loss of remaining kidney function in patients with impaired renal function. |
| Q91567271 | Phenome-wide association analysis suggests the APOL1 linked disease spectrum primarily drives kidney-specific pathways |
| Q37232156 | Polymorphisms in the non-muscle myosin heavy chain 9 gene (MYH9) are strongly associated with end-stage renal disease historically attributed to hypertension in African Americans |
| Q36888727 | Population need for renal replacement therapy in Thames regions: ethnic dimension |
| Q68790542 | Progressive renal disease: role of race and antihypertensive medications |
| Q41459743 | Race and ethnicity influences on cardiovascular and renal events in patients with diabetes mellitus. |
| Q46381116 | Race and renal impairment in heart failure: mortality in blacks versus whites |
| Q99206431 | Race, APOL1 Risk Variants, and Clinical Outcomes among Older Adults: The ARIC Study |
| Q36761340 | Race, Calcineurin Inhibitor Exposure, and Renal Function After Solid Organ Transplantation |
| Q46342599 | Race, socioeconomic status, and the development of end-stage renal disease |
| Q44625416 | Racial Differences in the Progression from Chronic Renal Insufficiency to End-Stage Renal Disease in the United States |
| Q36430075 | Racial and Ethnic Disparities in Graft and Recipient Survival in Elderly Kidney Transplant Recipients. |
| Q73308544 | Racial aspects of comorbidity in systemic lupus erythematosus |
| Q42584613 | Racial differences and hypertension |
| Q35133148 | Racial differences in the association of pentraxin-3 with kidney dysfunction: the Multi-Ethnic Study of Atherosclerosis |
| Q45302958 | Racial differences in the incidence and progression of renal diseases |
| Q73935113 | Racial differences in the incidence of end-stage renal disease |
| Q46164984 | Racial differences in the prevalence of chronic kidney disease among participants in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Cohort Study |
| Q44374344 | Racial differences in the prevalence of hypertensive retinopathy |
| Q43959239 | Regional and social inequalities in chronic renal replacement therapy in Denmark. |
| Q35632558 | Relationships of race and ethnicity to progression of kidney dysfunction and clinical outcomes in patients with chronic kidney failure |
| Q33870555 | Renal cell cancer among African Americans: an epidemiologic review |
| Q40767108 | Renal disease and black Americans: selected issues |
| Q41311372 | Renal disease in hypertensive adults: effect of race and type II diabetes mellitus |
| Q34215822 | Renal function and renal disease in the elderly: Part I. |
| Q41009553 | Renal hemodynamics in essential hypertension. Racial differences in response to changes in dietary sodium |
| Q43777282 | Renal outcomes in hypertensive Black patients at high cardiovascular risk |
| Q46720598 | Resting and ambulatory blood pressure differences in Afro-Caribbeans and Europeans |
| Q35159360 | Risk factors for progressive chronic kidney disease |
| Q81252876 | Roles of large and small arteries in vascular disease: pitfalls in interpreting ethnic variations |
| Q53860182 | Similar prevalence of renovascular hypertension in selected blacks and whites. |
| Q40436906 | Strict blood pressure control associates with decreased mortality risk by APOL1 genotype |
| Q34534909 | TGF-alpha mediates genetic susceptibility to chronic kidney disease. |
| Q34504302 | The RaDIANT community study protocol: community-based participatory research for reducing disparities in access to kidney transplantation |
| Q36491127 | The association between chronic renal failure and renal cell carcinoma may differ between black and white Americans |
| Q43884485 | The effect of race on access and outcome in transplantation |
| Q35569538 | The effect of salt on renal damage in eNOS-deficient mice |
| Q34543125 | The epidemiology of end-stage renal disease among African Americans |
| Q46726027 | The familial risk of end-stage renal disease in African Americans |
| Q46273914 | The genetic basis of kidney disease risk in African Americans: MYH9 as a new candidate gene |
| Q40497769 | The impact of gender on the progression of chronic renal disease |
| Q72760745 | The joint effects of race and age on the risk of end-stage renal disease attributed to hypertension |
| Q40586621 | The link between hypertension and nephrosclerosis |
| Q47359903 | The low birth weight hypothesis as a plausible explanation for the black/white differences in hypertension, non-insulin-dependent diabetes, and end-stage renal disease |
| Q33703667 | The need and demand for renal replacement therapy in ethnic minorities in England |
| Q35077654 | The role of gender in the progression of renal disease |
| Q34105121 | The spectrum of MYH9-associated nephropathy |
| Q53933122 | Time-Course Genetic Analysis of Albuminuria in Dahl Salt-Sensitive Rats on Low-Salt Diet |
| Q37018428 | Transfer of the CYP4A region of chromosome 5 from Lewis to Dahl S rats attenuates renal injury |
| Q34751792 | Vulnerable populations and the association between periodontal and chronic kidney disease |
| Q54403032 | [Latin American consensus on hypertension in patients with diabetes type 2 and metabolic syndrome]. |
Search more.